Docetaxel, Radiation Therapy, and Prednisone in Treating Patients Who Have Undergone Surgery For Prostate Cancer
Status:
Terminated
Trial end date:
2016-07-08
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as docetaxel and prednisone, work in different
ways to stop the growth of tumor cells, either by killing the cells or by stopping them from
dividing. Radiation therapy uses high-energy x-rays to kill tumor cells. Docetaxel may make
tumor cells more sensitive to radiation therapy. Giving docetaxel together with radiation
therapy and prednisone after surgery may kill any tumor cells that remain after surgery.
PURPOSE: This phase II trial is studying how well giving docetaxel together with radiation
therapy and prednisone works in treating patients who have undergone surgery for prostate
cancer.
Phase:
Phase 2
Details
Lead Sponsor:
The University of Texas Health Science Center at San Antonio